Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss - Full Text View

Study of Two Complementary and Alternative Medical Treatments for Maintenance of Weight Loss

This study has been terminated.

Sponsors and Collaborators:	National Center for Complementary and Alternative Medicine (NCCAM) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Information provided by:	National Center for Complementary and Alternative Medicine (NCCAM)
ClinicalTrials.gov Identifier:	NCT00069732

Purpose

The goal of this study is to pilot test in a group of overweight-obese individuals the feasibility and acceptability and indications of efficacy of two CAM treatments, qigong, and acupressure-TAT, for improving long term maintenance of weight loss.

Condition	Intervention	Phase
Obesity	Behavioral: qigong Behavioral: acupressure-TAT	Phase II

MedlinePlus related topics:

Obesity Weight Control

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Prevention, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study

Official Title:	Pilot of Two CAM Treatments for Maintenance of Weight Loss

Further study details as provided by National Center for Complementary and Alternative Medicine (NCCAM):

Estimated Enrollment:

Detailed Description:

The prevalence of obesity is at epidemic proportions, 60% of US adults are overweight or obese. Obesity contributes to chronic diseases (diabetes, cardiovascular disease [CVD], hypertension, cancer, and osteoarthritis) and to escalating health care costs. Weight loss can have a substantial impact on reducing these conditions. Substantial efforts have been made in developing effective short-term weight loss programs using behavioral treatments. However, long-term maintenance of weight loss continues to be problematic - many individuals regain the weight lost within a year. Innovative intervention options are critically needed to help people successfully maintain weight loss and to fight the obesity epidemic. Complementary and alternative medicine (CAM) approaches-mind-body, energy healing, and Traditional Chinese Medicine (TCM) approaches may hold great promise for helping improve the maintenance of weight loss.

Eligibility

Ages Eligible for Study:	18 Years to 80 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	Yes

Criteria

Inclusion Criteria:

BMI 25-35 kg/m 2
Reside in Portland metropolitan area
Willing to complete the 12-week weight loss program
Willing to accept random assignment to one of the three maintenance treatment conditions
Willing to provide informed consent

Exclusion Criteria:

Medical conditions or treatments that would be contraindicated using a diet & exercise weight loss treatment
Cancer
Significant GI disease inappropriate for diet and physical activity intervention
Diabetes dependent on insulin or oral hypoglycemic medications
Psychiatric hospitalization in past 2 years
Conditions that require limitation of physical activity
Congestive Heart Failure
Cardiovascular Disease (stroke, MI, CABG, ASCVD)
Taking weight loss medications currently or within past 6 months
Previous history of complementary or alternative medicine (CAM) weight loss treatment
Current acupressure, or Qi Gong, or acupuncture
Reported consumption of more than 21 alcoholic drinks per week
Planning to leave the area prior to the end of the program
Body weight change > 10 pounds in the 6 months prior to Screening visit one
Pregnant, breast feeding, or planning pregnancy prior to the end of participation
Current participation in another clinical trial
Investigator discretion for safety or adherence reasons
Household member of another CAM WT participant
Unavailable for group sessions

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00069732

Locations


United States, Oregon
	Center for Health Research
	Portland, Oregon, United States

Sponsors and Collaborators

National Center for Complementary and Alternative Medicine (NCCAM)

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Investigators


Principal Investigator:	Patricia J Elmer, PhD	Center for Health Research, Northwest

More Information

Study ID Numbers:	R21 AT001190-01A1
First Received:	September 30, 2003
Last Updated:	March 8, 2006
ClinicalTrials.gov Identifier:	NCT00069732
Health Authority:	United States: Federal Government